Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 0.76 is 19% below its 1-year average of 0.94, near the low end of its 1-year range (0.75–1.16).
As of 2026-10-06T22:21:45.129Z.
Calculation as of: 2026-10-06T22:21:45.129Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9199062e3d99303b6ceeba444dd11ff94fafae694fd5228a7a2e61ab73072144
PE Ratio (0.76) = Close Price ($2.05) / Diluted TTM EPS ($2.70)
PE RATIO
0.76
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.59
median of 187 covered companies
CURRENT VS SECTOR MEDIAN
-97.03%
vs the sector median at left
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $68.10M | 0.76 | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $67.52M | N/A | 70.55 | 70.55 | 70.55 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 10.82 | 12.57 | 15.78 | 15.78 |
| Champions Oncology, Inc. (CSBR)vs › | $69.61M | N/A | 26.91 | 41.68 | 277.63 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A | 0.90 | 0.90 | 0.90 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $70.63M | N/A | N/A | N/A | N/A |
| Gain Therapeutics, Inc. (GANX)vs › | $71.23M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | N/A | N/A | N/A |
At 0.8, P/E is below its 1-year median — higher than 2% of readings in its 1-year history.
1-year low
0.8
median
0.9
1-year high
1.2
Trailing P/E
0.8
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$2.05
Forward EPS (Est.)
$2.55
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 0.78 |
| 2026-10-02 | 0.76 |
| 2026-10-01 | 0.77 |
| 2026-09-30 | 0.80 |
| 2026-09-29 | 0.82 |
| 2026-09-28 | 0.81 |
| 2026-09-25 | 0.85 |
| 2026-09-24 | 0.85 |
| 2026-09-23 | 0.87 |
| 2026-09-22 | 0.91 |
| 2026-09-21 | 0.90 |
| 2026-09-18 | 0.94 |
| 2026-09-17 | 0.94 |
| 2026-09-16 | 0.92 |
| 2026-09-15 | 0.93 |
| 2026-09-14 | 0.94 |
| 2026-09-11 | 0.94 |
| 2026-09-10 | 0.96 |
| 2026-09-09 | 0.98 |
| 2026-09-08 | 1.01 |
| 2026-09-04 | 1.01 |
| 2026-09-03 | 1.01 |
| 2026-09-02 | 1.02 |
| 2026-09-01 | 1.00 |
| 2026-08-31 | 1.02 |
| 2026-08-28 | 1.03 |
| 2026-08-27 | 1.04 |
| 2026-08-26 | 1.05 |
| 2026-08-25 | 1.06 |
| 2026-08-24 | 1.09 |
| 2026-08-21 | 1.07 |
| 2026-08-20 | 1.03 |
| 2026-08-19 | 1.06 |
| 2026-08-18 | 1.08 |
| 2026-08-17 | 1.05 |
| 2026-08-14 | 1.09 |
| 2026-08-13 | 0.93 |
| 2026-08-12 | 0.86 |
| 2026-08-11 | 0.81 |
| 2026-08-10 | 0.86 |
| 2026-08-07 | 0.83 |
| 2026-08-06 | 0.86 |
| 2026-08-05 | 0.87 |
| 2026-08-04 | 0.85 |
| 2026-08-03 | 0.86 |
| 2026-07-31 | 0.98 |
| 2026-07-30 | 1.02 |
| 2026-07-29 | 1.04 |
| 2026-07-28 | 1.06 |
| 2026-07-27 | 1.02 |
| 2026-07-24 | 1.04 |
| 2026-07-23 | 1.07 |
| 2026-07-22 | 1.11 |
| 2026-07-21 | 1.10 |
| 2026-07-20 | 1.04 |
| 2026-07-17 | 1.05 |
| 2026-07-16 | 1.07 |
| 2026-07-15 | 1.16 |
| 2026-07-14 | 1.16 |
| 2026-07-13 | 1.03 |
| 2026-07-10 | 1.03 |
| 2026-07-09 | 1.02 |
| 2026-07-08 | 0.93 |
| 2026-07-07 | 0.93 |
| 2026-07-06 | 0.92 |
| 2026-07-02 | 0.95 |
| 2026-07-01 | 0.96 |
| 2026-06-30 | 0.95 |
| 2026-06-29 | 0.92 |
| 2026-06-26 | 0.86 |
| 2026-06-25 | 0.94 |
| 2026-06-24 | 0.98 |
| 2026-06-23 | 0.98 |
| 2026-06-22 | 0.96 |
| 2026-06-18 | 0.93 |
| 2026-06-17 | 0.96 |
| 2026-06-16 | 0.91 |
| 2026-06-15 | 0.89 |
| 2026-06-12 | 0.86 |
| 2026-06-11 | 0.86 |
| 2026-06-10 | 0.86 |
| 2026-06-09 | 0.91 |
| 2026-06-08 | 0.89 |
| 2026-06-05 | 0.83 |
| 2026-06-04 | 0.86 |
| 2026-06-03 | 0.81 |
| 2026-06-02 | 0.83 |
| 2026-06-01 | 0.80 |
| 2026-05-29 | 0.87 |
| 2026-05-28 | 0.88 |
| 2026-05-27 | 0.86 |
| 2026-05-26 | 0.84 |
| 2026-05-22 | 0.85 |
| 2026-05-21 | 0.87 |
| 2026-05-20 | 0.83 |
| 2026-05-19 | 0.79 |
| 2026-05-18 | 0.77 |
| 2026-05-15 | 0.75 |